Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | 43.76 | |
2 | Current Medicinal Chemistry | journal | 0.934 Q1 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | 47.17 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.706 Q2 | 133 | 240 | 735 | 21755 | 2287 | 620 | 2.65 | 90.65 | 44.44 | |
4 | Iranian Journal of Pharmaceutical Research | journal | 0.370 Q2 | 58 | 168 | 604 | 6572 | 1193 | 598 | 1.81 | 39.12 | 44.98 | |
5 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | 41.05 | |
6 | Iranian Journal of Basic Medical Sciences | journal | 0.611 Q2 | 57 | 222 | 571 | 11015 | 1643 | 565 | 2.77 | 49.62 | 42.89 | |
7 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | 40.00 | |
8 | Letters in Drug Design and Discovery | journal | 0.223 Q3 | 37 | 144 | 426 | 5796 | 461 | 413 | 1.11 | 40.25 | 38.05 | |
9 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q2 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | 42.91 | |
10 | Current Drug Delivery | journal | 0.449 Q2 | 72 | 76 | 320 | 5298 | 764 | 303 | 2.63 | 69.71 | 42.09 | |
11 | Journal of Research in Pharmacy | journal | 0.214 Q3 | 20 | 94 | 275 | 3359 | 276 | 273 | 0.89 | 35.73 | 56.82 | |
12 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | 39.63 | |
13 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | 44.61 | |
14 | Combinatorial Chemistry and High Throughput Screening | journal | 0.292 Q3 | 70 | 109 | 272 | 4931 | 367 | 251 | 1.15 | 45.24 | 41.28 | |
15 | Current Pharmaceutical Analysis | journal | 0.210 Q3 | 27 | 137 | 241 | 5109 | 206 | 239 | 0.86 | 37.29 | 44.26 | |
16 | Medicinal Chemistry | journal | 0.308 Q3 | 50 | 92 | 242 | 4815 | 575 | 238 | 2.29 | 52.34 | 44.69 | |
17 | Iranian Journal of Medical Sciences | journal | 0.399 Q2 | 40 | 67 | 249 | 1878 | 423 | 234 | 1.65 | 28.03 | 44.94 | |
18 | Advanced Pharmaceutical Bulletin | journal | 0.773 Q1 | 56 | 80 | 239 | 4247 | 1035 | 233 | 3.55 | 53.09 | 38.18 | |
19 | Current Cancer Drug Targets | journal | 0.972 Q1 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | 38.95 | |
20 | International Journal of Genomics | journal | 0.705 Q2 | 37 | 62 | 223 | 3036 | 598 | 217 | 2.38 | 48.97 | 39.89 | |
21 | Records of Natural Products | journal | 0.430 Q3 | 41 | 49 | 216 | 1263 | 394 | 215 | 1.83 | 25.78 | 45.69 | |
22 | Current Nanoscience | journal | 0.285 Q3 | 52 | 88 | 212 | 6490 | 351 | 203 | 1.74 | 73.75 | 33.14 | |
23 | Current Vascular Pharmacology | journal | 0.806 Q2 | 69 | 76 | 225 | 5973 | 643 | 197 | 2.27 | 78.59 | 30.77 | |
24 | Archives of Clinical Infectious Diseases | journal | 0.220 Q4 | 22 | 80 | 214 | 2012 | 171 | 191 | 0.62 | 25.15 | 45.61 | |
25 | Journal of Medicinal Plants | journal | 0.168 Q4 | 27 | 96 | 191 | 3517 | 91 | 190 | 0.44 | 36.64 | 42.39 | |
26 | Turkish Journal of Pharmaceutical Sciences | journal | 0.241 Q3 | 22 | 97 | 167 | 3281 | 185 | 167 | 0.96 | 33.82 | 52.66 | |
27 | Current Bioactive Compounds | journal | 0.269 Q2 | 31 | 133 | 162 | 6765 | 246 | 156 | 1.31 | 50.86 | 39.05 | |
28 | Pharmaceutical Sciences | journal | 0.238 Q3 | 26 | 69 | 146 | 2824 | 205 | 140 | 0.93 | 40.93 | 41.56 | |
29 | Journal of HerbMed Pharmacology | journal | 0.341 Q3 | 18 | 51 | 127 | 2371 | 235 | 126 | 2.13 | 46.49 | 43.63 | |
30 | Archives of Razi Institute | journal | 0.238 Q4 | 16 | 46 | 115 | 1158 | 88 | 115 | 0.77 | 25.17 | 24.30 | |
31 | Reviews on Recent Clinical Trials | journal | 0.509 Q3 | 35 | 44 | 130 | 1929 | 200 | 115 | 1.47 | 43.84 | 32.78 | |
32 | Current Drug Safety | journal | 0.334 Q3 | 41 | 36 | 117 | 1064 | 177 | 114 | 1.79 | 29.56 | 40.52 | |
33 | Current Gene Therapy | journal | 0.704 Q2 | 80 | 38 | 129 | 2994 | 406 | 113 | 3.25 | 78.79 | 44.16 | |
34 | Infectious Disorders - Drug Targets | journal | 0.322 Q3 | 61 | 122 | 116 | 4449 | 166 | 112 | 1.47 | 36.47 | 44.14 | |
35 | Physiology and Pharmacology (Iran) | journal | 0.200 Q4 | 15 | 34 | 106 | 1631 | 69 | 104 | 0.56 | 47.97 | 42.76 | |
36 | Current Drug Discovery Technologies | journal | 0.319 Q3 | 49 | 70 | 105 | 4231 | 180 | 101 | 1.78 | 60.44 | 41.58 | |
37 | Journal of Reports in Pharmaceutical Sciences | journal | 0.155 Q3 | 12 | 35 | 100 | 1542 | 57 | 100 | 0.59 | 44.06 | 46.15 | |
38 | Current Computer-Aided Drug Design | journal | 0.226 Q4 | 32 | 73 | 111 | 3171 | 129 | 99 | 1.36 | 43.44 | 36.29 | |
39 | BioImpacts | journal | 0.743 Q1 | 47 | 34 | 95 | 1281 | 396 | 92 | 3.60 | 37.68 | 39.33 | |
40 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 28 | 95 | 1263 | 209 | 89 | 2.51 | 45.11 | 41.82 | ||
41 | Acta Pharmaceutica Sciencia | journal | 0.215 Q3 | 23 | 32 | 97 | 909 | 108 | 86 | 0.98 | 28.41 | 58.67 | |
42 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | 33.94 | |
43 | Current Radiopharmaceuticals | journal | 0.586 Q3 | 32 | 23 | 92 | 922 | 228 | 84 | 3.09 | 40.09 | 37.50 | |
44 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.365 Q3 | 45 | 41 | 86 | 1604 | 141 | 81 | 1.64 | 39.12 | 36.49 | |
45 | Current Molecular Pharmacology | journal | 0.717 Q2 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | 44.76 | |
46 | Iranian Journal of Pharmaceutical Sciences | journal | 0.140 Q4 | 16 | 38 | 81 | 1045 | 26 | 81 | 0.29 | 27.50 | 50.78 | |
47 | Journal of Toxicology | journal | 0.829 Q2 | 47 | 35 | 78 | 1600 | 383 | 77 | 5.22 | 45.71 | 36.31 | |
48 | Fabad Journal of Pharmaceutical Sciences | journal | 0.150 Q3 | 19 | 27 | 71 | 1325 | 35 | 71 | 0.55 | 49.07 | 62.22 | |
49 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 19 | 72 | 1241 | 129 | 66 | 2.00 | 65.32 | 56.14 | ||
50 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 24 | 61 | 1475 | 27 | 56 | 0.40 | 61.46 | 31.15 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®